Paper11222697
Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.
York J and 5 others. J Virol, 2001. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. Papers, record 11222697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11222697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Antibody Affinity | |
| Cell Line | |
| Flow Cytometry | |
| Gene Products, env | |
| Humans | |
| Neutralization Tests | |
| T-Lymphocytes | |
| Transfection | |
| Virion |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI44312 | NIAID NIH HHS | United States | R21AI044312 | PubMed and NIH | NIH RePORTER |
| R01 AI036085 | NIAID NIH HHS | United States | R01AI036085 | PubMed and NIH | NIH RePORTER |
| AI32424 | NIAID NIH HHS | United States | R01AI032424 | PubMed and NIH | NIH RePORTER |
| AI36085 | NIAID NIH HHS | United States | R01AI036085 | PubMed and NIH | NIH RePORTER |
| AI44669 | NIAID NIH HHS | United States | R01AI044669 | PubMed and NIH | NIH RePORTER |
| R01 HL059725 | NHLBI NIH HHS | United States | R01HL059725 | PubMed and NIH | NIH RePORTER |
| HL59725 | NHLBI NIH HHS | United States | R01HL059725 | PubMed and NIH | NIH RePORTER |
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8709238 | Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses. | J Virol | 1996 | https://conductscience.org/library/papers/8709238 | PubMed |
| 2 | 2564898 | Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. | J Virol | 1989 | https://conductscience.org/library/papers/2564898 | PubMed |
| 3 | 9814710 | Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. | Cell | 1998 | https://conductscience.org/library/papers/9814710 | PubMed |
| 4 | 2018048 | Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4. | Am J Med | 1991 | https://conductscience.org/library/papers/2018048 | PubMed |
| 5 | 9888845 | RETRACTED: Fusion-competent vaccines: broad neutralization of primary isolates of HIV. | Science | 1999 | https://conductscience.org/library/papers/9888845 | PubMed |
| 6 | 8347397 | Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4. | AIDS Res Hum Retroviruses | 1993 | https://conductscience.org/library/papers/8347397 | PubMed |
| 7 | 9499111 | Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity. | J Virol | 1998 | https://conductscience.org/library/papers/9499111 | PubMed |
| 8 | 7693970 | Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. | J Virol | 1993 | https://conductscience.org/library/papers/7693970 | PubMed |
| 9 | 7786580 | Increase in sensitivity to soluble CD4 by primary HIV type 1 isolates after passage through C8166 cells: association with sequence differences in the first constant (C1) region of glycoprotein 120. | AIDS Res Hum Retroviruses | 1995 | https://conductscience.org/library/papers/7786580 | PubMed |
| 10 | 2002552 | Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. | J Virol | 1991 | https://conductscience.org/library/papers/2002552 | PubMed |
| 11 | 9400598 | Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. | Virology | 1997 | https://conductscience.org/library/papers/9400598 | PubMed |
| 12 | 10888925 | Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. | Nat Med | 2000 | https://conductscience.org/library/papers/10888925 | PubMed |
| 13 | 8819579 | HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. | AIDS | 1995 | https://conductscience.org/library/papers/8819579 | PubMed |
| 14 | 9499039 | Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. | J Virol | 1998 | https://conductscience.org/library/papers/9499039 | PubMed |
| 15 | 2395859 | High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2395859 | PubMed |
| 16 | 7692082 | A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. | J Virol | 1993 | https://conductscience.org/library/papers/7692082 | PubMed |
| 17 | 2974157 | Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2974157 | PubMed |
| 18 | 9764911 | Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41. | AIDS Res Hum Retroviruses | 1998 | https://conductscience.org/library/papers/9764911 | PubMed |
| 19 | 8312057 | Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. | AIDS Res Hum Retroviruses | 1993 | https://conductscience.org/library/papers/8312057 | PubMed |
| 20 | 7685962 | Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. | Virology | 1993 | https://conductscience.org/library/papers/7685962 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41648506 | Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648506 | PubMed |
| 38289101 | Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells. | J Virol | 2024 | https://conductscience.org/library/papers/38289101 | PubMed |
| 35770989 | Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14+ Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines. | J Virol | 2022 | https://conductscience.org/library/papers/35770989 | PubMed |
| 34549974 | Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer. | J Virol | 2021 | https://conductscience.org/library/papers/34549974 | PubMed |
| 33148792 | Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions. | J Virol | 2021 | https://conductscience.org/library/papers/33148792 | PubMed |
| 29618643 | Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers. | J Virol | 2018 | https://conductscience.org/library/papers/29618643 | PubMed |
| 26113642 | HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein. | Science | 2015 | https://conductscience.org/library/papers/26113642 | PubMed |
| 26018167 | Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope. | J Virol | 2015 | https://conductscience.org/library/papers/26018167 | PubMed |
| 24884925 | Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers. | Retrovirology | 2014 | https://conductscience.org/library/papers/24884925 | PubMed |
| 19574645 | Production, purification, crystallization and preliminary X-ray diffraction analysis of the HIV-2-neutralizing V3 loop-specific Fab fragment 7C8. | Acta Crystallogr Sect F Struct Biol Cryst Commun | 2009 | https://conductscience.org/library/papers/19574645 | PubMed |
| 18822440 | Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity. | Virology | 2008 | https://conductscience.org/library/papers/18822440 | PubMed |
| 18031785 | N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus. | Virology | 2008 | https://conductscience.org/library/papers/18031785 | PubMed |
| 16956933 | Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization. | J Virol | 2006 | https://conductscience.org/library/papers/16956933 | PubMed |
| 16699036 | Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif. | J Virol | 2006 | https://conductscience.org/library/papers/16699036 | PubMed |
| 16140761 | Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity. | J Virol | 2005 | https://conductscience.org/library/papers/16140761 | PubMed |
| 15994775 | Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. | J Virol | 2005 | https://conductscience.org/library/papers/15994775 | PubMed |
| 14607875 | Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats. | Clin Diagn Lab Immunol | 2003 | https://conductscience.org/library/papers/14607875 | PubMed |
| 12857927 | Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients. | J Virol | 2003 | https://conductscience.org/library/papers/12857927 | PubMed |
| 12502824 | Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site. | J Virol | 2003 | https://conductscience.org/library/papers/12502824 | PubMed |
| 12477867 | Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. | J Virol | 2003 | https://conductscience.org/library/papers/12477867 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ERVK-6 | 64006 | PubTator's text mining | https://conductscience.org/library/genes/64006 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11222697
GET https://conductscience.org/api/papers/v1/11222697/references?page=2